Greenwich LifeSciences, Inc. (GLSI) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Greenwich LifeSciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
High 19.63 at 3:30 pm ET, low 18.40 at 7:00 am ET.
the bull case· 2
58
managers reporting a position in thirteen f filings
13fJun 30 '26+6.89%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 3
5 of 20
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '260.01%
of iShares Russell two thousand ETF's assets as the largest fund weight on file
n-portJun 30 '269
managers whose positions together make up four fifths of reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 10 '26 report. Not a forecast, not advice.
Of the 6 companies Greenwich LifeSciences, Inc. moves with most closely, none share its SEC classification.
Measured against 134 trading days of our own closes. Co-movement, not cause.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
57 managers report a position worth $39.6M between them, and 9 of them hold 80% of it.
tall tick = annual report · 1 on record
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
GLSI (Greenwich LifeSciences, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.